Research investigates a novel strategy for inhibiting the spread of Vibrio cholerae

Karl Klose, director of The South Texas Center for Emerging Infectious Diseases (STCEID) and the Robert J. Kleberg, Jr. and Helen C. Kleberg College of Sciences Endowed Professor, coauthored a research article with Cameron Lloyd ’23, a UTSA doctoral student who graduated in August with a Ph.D. in molecular microbiology and immunology under the guidance of Klose.

Keytruda remains Merck & Co’s biggest 2023 success story as patent expiry looms – Pharmaceutical Technology

Share this article MSD is anticipating worldwide sales of between $62.7bn and $64.2bn for full-year 2024. Credit: rafapress via Shutterstock. MSD has reported its FY

February 3, 2024

Early life food allergy associated with increased risk of asthma and reduced lung growth

Having a food allergy as a baby is linked to asthma and reduced lung function later in childhood, according to a world first study.

July 25, 2023

Ipsen joins the ADC club with deal worth up to $900m – Pharmaceutical Technology

Share this article Ipsen signed a deal with Sutro Biopharma for ADC development. Credit: HJBC via Shutterstock Ipsen has joined the slew of companies developing

April 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.